Efavirenz (Sustiva, Stocrin): News
- FDA Updates Efavirenz Labeling With Expanded Pediatric Indication Information (May 7, 2013)
From AIDSinfo
- Efavirenz Dose Increase to 800 mg QD With Rifampin in Patients >50 kg (January/February 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Updated Label Information for Sustiva (Efavirenz) (April 14, 2010)
From U.S. Food and Drug Administration
- Maker of Reyataz and Sustiva Announces Enhancements to Co-Pay Benefit Program (January 21, 2010)
From TheBody.com
- Efavirenz Treatment and False-Positive Results in Benzodiazepine Screening Tests (June 15, 2009)
In Clinical Infectious Diseases
- A Cheaper, Safer Sustiva? Gates Foundation to Fund Trials of Lower HIV Drug Doses (April 29, 2009)
From aidsmap.com
- Reyataz and Sustiva Co-Pay Benefit Program (April 16, 2009)
If you live in the U.S., you might be eligible for a benefits program created to help people who are already insured, but still need help to pay for Reyataz or Sustiva.
From Bristol-Myers Squibb Company
- South African Addicts Turn to AIDS Medication to Get High (July 7, 2008)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Brazilian President Silva Issues Compulsory License for Merck's Antiretroviral Efavirenz (May 7, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Important Update to Sustiva Package Insert (January 31, 2007)
From U.S. Food and Drug Administration
- Pregnancy Risk Category Raised for Efavirenz (Summer 2005)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Efavirenz-Associated Neural Tube Defects Reported in Infants; Pregnancy Category Changed From C to D (March 31, 2005)
From U.S. Food and Drug Administration
- Efavirenz, Stavudine Demand May Soon Exceed Supply in Developing World (March 4, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Warning on Two Specific 3-Drug Regimens: Viread + Videx + Either Sustiva or Viramune (November 23, 2004)
A brief comment on the recently issued warning that both regimens frequently fail.
In AIDS Treatment News, from AIDS Treatment News
- Merck to Cut Cost of AIDS Drug in Poorest Nations (October 23, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- FDA Approves Once-Daily Efavirenz Formulation, Revised Labeling (March 8, 2002)
In AIDS Treatment News, from AIDS Treatment News
- New Formulation of Sustiva Available (March 2002)
In What's New, from Project Inform
- Sustiva (Efavirenz) in New Formulation (February 8, 2002)
To read PDF, click here.
In STEP Ezine, from Seattle Treatment Education Project
- Sustiva Seems to Cause Prisoners to Wrongly Test Positive for Marijuana Use (November/December 2001)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Nelfinavir, Efavirenz, or Both After the Failure of Nucleoside Treatment of HIV Infection (August 9, 2001)
In New England Journal of Medicine
- Efavirenz (Sustiva®): Oral Liquid Expanded Access Program for Children and Adolescents Ages 3-16 (May 5, 2000)
In AIDS Treatment News, from AIDS Treatment News
|
Advertisement
|
Email
Glossary
